ArticleCurrent pharmaceutical design2024

Discovery of an EP300 Inhibitor using Structure-based Virtual Screening and Bioactivity Evaluation.

Dabo Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.